Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02574621

Ligand	Ligand name	Chain	PDB	Tanimoto
EGT	2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL	A	1JNQ	0.71
TL3	2,5-BIS-O-{4-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL	T	1Y5B	0.72
TL1	2,5-BIS-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL	T	1Y59	0.71
PNT	1,5-BIS(4-AMIDINOPHENOXY)PENTANE	X	3CR4	0.71
PNT	1,5-BIS(4-AMIDINOPHENOXY)PENTANE	B	1D64	0.71
PNT	1,5-BIS(4-AMIDINOPHENOXY)PENTANE	X	3CR5	0.71
PNT	1,5-BIS(4-AMIDINOPHENOXY)PENTANE	A,B,D,E	1RKW	0.71
FIL	(1E)-1-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]ETHANONE O-(AMINOCARBONYL)OXIME	A,B	1XLZ	0.7
L4G	6-(4-METHYLSULFONYL-PHENYL)-5-[4-(2-PIPERIDIN-1-YLETHOXY)PHENOXY]NAPHTHALEN-2-OL	A	2AYR	0.7
OHT	4-HYDROXYTAMOXIFEN	A	3ERT	0.77
OHT	4-HYDROXYTAMOXIFEN	A,B	1S9Q	0.77
OHT	4-HYDROXYTAMOXIFEN	A,B	1VJB	0.77
OHT	4-HYDROXYTAMOXIFEN	A,B,C,P,R	2JF9	0.77
OHT	4-HYDROXYTAMOXIFEN	A,B,C,D,E,F	2GPV	0.77
OHT	4-HYDROXYTAMOXIFEN	A	2GPU	0.77
OHT	4-HYDROXYTAMOXIFEN	A	2P7Z	0.77
OHT	4-HYDROXYTAMOXIFEN	A,B	2BJ4	0.77
OHT	4-HYDROXYTAMOXIFEN	A,B	2FSZ	0.77
55E	4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one	A	3DCV	0.71
369	5-(4-hydroxyphenoxy)-6-(3-hydroxyphenyl)-7-methylnaphthalen-2-ol	A,B	3DT3	0.74
I0G	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	A,B	2I0G	0.77
I0G	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	A,B,C,D	2I0J	0.77
TL2	2-O-{4-[AMINO(IMINO)METHYL]PHENYL}-5-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL	T	1Y5A	0.72
JJ3	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	A,B	2JJ3	0.77
JJ3	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	A,B	2QE4	0.77
HMK	(6AR,12AR)-6H-[1,3]DIOXOLO[5,6][1]BENZOFURO[3,2-C]CHROMENE-3,6A(12AH)-DIOL	A	1ZGA	0.7
WST	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL	A,B	2POG	0.72
3AS	(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	A,B	2QTU	0.75
AIT	(2S,3R)-3-(4-HYDROXYPHENYL)-2-(4-{[(2R)-2-PYRROLIDIN-1-YLPROPYL]OXY}PHENYL)-2,3-DIHYDRO-1,4-BENZOXATHIIN-6-OL	A	1XPC	0.73
AIU	(2S,3R)-2-(4-{2-[(3S,4S)-3,4-DIMETHYLPYRROLIDIN-1-YL]ETHOXY}PHENYL)-3-(4-HYDROXYPHENYL)-2,3-DIHYDRO-1,4-BENZOXATHIIN-6-OL	A	1XP6	0.72
CM4	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIM	0.82
TXF	(Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL	A,B,C,D,E	2EWP	0.77
DC8	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	A,B	2Q70	0.75
DC8	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	A,B	2Z4B	0.75
AIH	(2S,3R)-2-(4-{2-[(3R,4R)-3,4-DIMETHYLPYRROLIDIN-1-YL]ETHOXY}PHENYL)-3-(4-HYDROXYPHENYL)-2,3-DIHYDRO-1,4-BENZOXATHIIN-6-OL	A	1XP1	0.72
TAX	(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINIUM	A	1FJ5	0.7
RNP	(1E,2R)-1-(ISOPROPYLIMINO)-3-(1-NAPHTHYLOXY)PROPAN-2-OL	X	1H46	0.76
M07	(5R,7R,8S,9S,10R)-7-(HYDROXYMETHYL)-3-(4-METHOXYPHENYL)-1,6-DIOXA-2-AZASPIRO[4.5]DEC-2-ENE-8,9,10-TRIOL	A	2QRG	0.73
TL4	2-O-{3-[AMINO(IMINO)METHYL]PHENYL}-5-O-{4-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL	T	1Y5U	0.72
E4D	(2S,3R)-2-(4-(2-(PIPERIDIN-1-YL)ETHOXY)PHENYL)-2,3-DIHYDRO-3-(4-HYDROXYPHENYL)BENZO[B][1,4]OXATHIIN-6-OL	A	1SJ0	0.71
CM3	(2R,3R,4S)-5-FLUORO-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIN	0.78
AIJ	(2S,3R)-3-(4-HYDROXYPHENYL)-2-(4-{[(2S)-2-PYRROLIDIN-1-YLPROPYL]OXY}PHENYL)-2,3-DIHYDRO-1,4-BENZOXATHIIN-6-OL	A	1XP9	0.73
C3D	(5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL	A	2OUZ	0.75
CTX	(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE	A,B,C	1YA4	0.73